CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Aldeyra Therapeutics Seeks FDA Clarification on Reproxalap NDA Meeting Minutes

NDA FilingReproxalapNeutral
AI Analysis

Summary

Aldeyra Therapeutics is seeking FDA clarification regarding meeting minutes related to its Reproxalap NDA submission.

Importance:3/10
Sentiment:
0.00
NDAFDAregulatoryreproxalap
Related Companies

Read the original article

Published by yahoo_finance on July 16, 2026 10:44 AM

Read Original